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Case Report
Wilms’ Tumor with Long-delayed Recurrence: 25 Years after Initial 
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Wilms’ tumor is one of the most frequent malignant neoplasms in childhood. Advances 
in treatment modalities such as the combination of chemoradiation therapy with sur-
gery have enhanced overall survival. However, recurrence of Wilms’ tumor is still a 
problem. In this case, a 28-year-old female had experienced intermittent abdominal 
pain, and the computed tomography scan showed a huge pelvic mass. The patient had 
a history of radical nephrectomy for Wilms’ tumor with concurrent chemotherapy at 
the age of three. The pelvic mass was resected in February 2010 and was confirmed 
to be a recurrent Wilms’ tumor. The recurrent tumor showed a classic triphasic Wilms’
tumor growth pattern with frequent mitoses and tumor necrosis. Our case is an extra-
ordinary case of a long-delayed recurrent Wilms’ tumor after 25 years, which is the lon-
gest disease-free interval ever reported. The possible effects of chemotherapy as well 
as some other mechanisms of this late relapse are discussed.
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Wilms’ tumor is one of the most common malignant neo-
plasms in childhood. It typically occurs in children less 
than 5 years of age and rarely in adults. Wilms’ tumor is 
highly responsive to chemotherapy and radical neph-
rectomy, with about 90% of patients surviving at least 5 
years, particularly patients with localized disease and fa-
vorable histology [1-3]. Despite therapeutic improve-
ments, however, a subset of patients suffers from tumor 
relapse. In developing countries, the relapse rate has been 
reported to be 15 to 20% [4,5]. 
Recently, we experienced a case of Wilms’ tumor that re-
curred 25 years after the primary diagnosis and treatment. 
To the best of our knowledge, this is the most delayed case 
of recurrence ever reported in the English literature. 
CASE REPORT
A 28-year-old female had experienced intermittent ab-
dominal pain for 3 months and visited the Asan Medical 
Center, Seoul, South Korea, for further evaluation and 
treatment. An abdominal-pelvic computed tomography 
scan taken in January 2010 at the Asan Medical Center re-
vealed a huge mass involving most of the lower abdomen 
and pelvic cavity with multiple septations and areas of en-
hancement (Fig. 1). The provisional diagnosis on the basis 
of the image findings was either borderline or malignant 
ovarian neoplasm. Neither ascites nor metastatic lympha-
denopathy was found. 
The patient had a history of radical nephrectomy for 
Wilms’ tumor of the right kidney 25 years previously, at the 
age of 3 years, in April 1985 at an outside hospital. After 
surgery, she had been treated with intravenous injection 
of dactinomycin 25 mcg for 5 days and vincristine 1 mg on 
the 7th day after the operation. Since then, she had been 
healthy with no evidence of recurrence or metastasis until 
she noticed abdominal pain in September 2009.
Under the clinical diagnosis of an ovarian tumor, the pel-
vic mass was resected in February 2010. During surgery, 
the mass was noted to occupy the entire lower abdominal 
cavity without involving both adnexa. Intraoperative con-
sultation was made and the frozen section diagnosis was 
malignant gastrointestinal stromal tumor or other malig-Korean J Urol 2012;53:288-292
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FIG. 1. Computed tomographic finding showing a huge mass 
with enhancing solid portion involving almost the entire lower 
abdominal cavity.
FIG. 2. Grossly, the recurrent 30-cm mass had a yellowish pink 
to red, firm and lobulating cut surface with focal hemorrhage 
and necrosis.
nant mesenchymal tumor such as leiomyosarcoma with 
pending evaluation of permanent sections. 
The original slides of the Wilms’ tumor, resected 25 years 
ago, could not be reviewed because the slides were not avail-
able in the file of the outside hospital. However, the outside 
pathology report stated that the size of the tumor was 12 
cm and it was located at the right kidney. The tumor was 
abutting the head of the pancreas, and in the operation re-
cord it was written that the tumor was not completely 
excised. Microscopically, the tumor was shown to be a clas-
sic Wilms’ tumor with predominant epithelial tubular ele-
ments and minor blastemal and mesenchymal components. 
No anaplasia or lymphovascular invasion was recorded, 
and the mitotic count was stated as scant. The final diag-
nosis of the nephrectomy specimen was Wilms’ tumor, 
stage III. 
Grossly, the resected tumor in February 2010 was a 
30-cm, previously ruptured, solid and cystic mass. On the 
cut surface, the tumor was heterogeneous, pinkish tan to 
yellow, and had both solid and friable areas. Multifocal 
hemorrhagic, cystic, and necrotic changes were also noted 
(Fig. 2). Microscopically, the tumor was composed of three 
different cell types, epithelial, mesenchymal, and blaste-
mal components (Fig. 3A). Areas of tumor necrosis were 
seen (Fig. 3B). The mesenchymal tumor cells were short, 
spindle-shaped to round cells with scanty cytoplasm in a 
myxoid background (Fig. 3C). The epithelial cell compo-
nent formed tumor cell nests with glandular architecture 
(Fig. 3D). The majority of the tumor compartment was an 
undifferentiated blastemal cell component. Mitoses were 
frequently observed up to 30/10 HPFs, particularly in the 
blastemal component. Hyperchromatism was also ob-
served, but significant pleomorphism was not obvious (Fig. 
3E). Immunohistochemical staining was done and the re-
sults were as follows: focal positive for cytokeratin in the 
epithelial component but negative in the blastemal and 
mesenchymal components (Fig. 4A). The Ki-67 labeling in-
dex was positive in about 50% of the tumor cells (Fig. 4B), 
and p53 staining was positive in about one third of the tu-
mor cells in all three elements. The immunohistochemical 
staining for WT-1, S-100 protein, SMA, desmin, myogenin, 
myoglobin, CD117, and CD34 was negative in all three 
components. 
On the basis of the histologic findings in conjunction with 
the immunohistochemical findings, the tumor was diag-
nosed as a recurrent classic Wilms’ tumor without ana-
plastic changes.
DISCUSSION
Wilms’ tumor relapse is not uncommon and accounts for ap-
proximately 15% of Wilms’ tumors with favorable histology 
[6]. Most recurrent Wilms’ tumors have been reported to 
occur in the first 2 years after the primary diagnosis. By 
contrast, long-delayed late recurrences, defined as 5 years 
after the initial diagnosis, are extremely rare events, and 
most of them have been reported in the form of individual 
case reports (Table 1) [1,7-10].
Among the previously reported late recurrence cases, all 
but two cases showed similar histological features between 
the original and the recurrent tumors, with persistence of 
immature blastematous elements or nephrogenic rests 
[1,7]. The two cases with different morphologic features be-
tween the primary and recurrent tumors had a tumor re-
lapsing interval of 23 years. They both showed differ-
entiated epithelial cell components and extensive mature 
skeletal muscle elements, which are known to be resistant 
to chemotherapy. In the present case, the recurrent tumor 
showed histologic features similar to the original tumor, 
with the classic Wilms’ tumor histology, according to the Korean J Urol 2012;53:288-292
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FIG. 3. (A) Microscopically, the recurrent tumor showed a 
classic triphasic growth pattern with blastemal, epithelial, and 
mesenchymal components (H&E, x40). (B) Hypercellular bla-
stemal element with adjacent tumor necrosis (H&E, x40). (C) 
Short spindle mesenchymal cells in myxoid background (H&E, 
x400). (D) Epithelial component with tubular growth pattern 
(H&E, x400). (E) Undifferentiated blastemal cells with frequ-
ent mitoses (H&E, x400).
pathology report, although there were some proportional 
differences.
Preoperative chemotherapy is thought to be associated 
with changes in histological features, and the therapeutic 
effects can vary according to the different tumor compo-
nents of a Wilms’ tumor. In a recent report by Senetta et 
al. [1] preoperative chemotherapy was shown to be able to 
enhance tumor differentiation, thus inducing tumor matu-
ration with ablation of immature tumor components. In 
that study, the authors hypothesized that there are two dif-
ferent types of Wilms’ tumor recurrence as follows: 1) the 
first group comprises cases in which chemotherapy is not 
effective, in which tumor recurrences have a short dis-
ease-free interval with a more undifferentiated tumor and Korean J Urol 2012;53:288-292
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FIG. 4. (A) Immunohistochemical staining of cytokeratin showing positivity in the epithelial component (x400). (B) Immuno-
histochemical staining of Ki-67 showing 50% positivity in tumor cells (x200).
TABLE 1. Clinicopathological summary of patients showing late-recurring Wilms’ tumors
Senetta et al. [1] 
Gottesman 
et al. [7]
Gallego-Melcón 
et al. [8] 
Pinarli et al. [9]
Gibson 
et al. [10]
Present case
Age 10 mo 5 yr 6 yr 9 yr  2 yr 3 yr
Gender F M M F F F
Relapse time (yr) 23  23  20  9  13 25 
Primary tumor 
histology and 
stage
Rhabdomyoblastic 
differentiation 
Stage III
Predominant 
blastematous 
with tubular 
elements 
Unknown stage
Classic Wilms’ 
tumor with no 
evidence of 
anaplasia 
Stage I
Classic Wilms’ 
tumor with no 
evidence of 
anaplasia 
Stage III
Not specified 
Unknown 
stage
Predominant 
tubular 
epithelial 
component 
Stage III
Additional 
treatment
CTX RTX CTX CTX CTX+RTX CTX+RTX
Location Retroperitoneum Tumor  bed Lung Abdomen  Lung  Pelvic  cavity
Histologic 
features
Extensive 
skeletal muscle 
differentiation
More ductal 
and 
glomerular 
elements
High mitotic 
rate 
Rhabdomyomatous 
differentiation
Not specified High mitotic rate 
and pronounced 
blastemal 
component
more aggressive behavior, and 2) the second group com-
prises cases in which chemotherapy is effective, and tumor 
recurrences show a long disease-free interval with a high 
degree of differentiation and better survival related to the 
previous therapy. It can be postulated that if treatment is 
effective, the immature components of the tumor are more 
sensitive to preoperative chemotherapy and radiation 
treatment and are prone to be ablated more easily than are 
the mature components [1]. 
The present case recurred 25 years after the primary 
Wilms’ tumor was diagnosed and treated with combined 
surgery and chemoradiation, and to the best of our knowl-
edge, this is the longest disease-free interval reported in 
the English literature. According to the outside hospital 
pathology report, the primary kidney tumor of the current 
reported case was mostly composed of epithelial tubular 
components with lesser amounts of blastemal and mesen-
chymal components and without anaplastic features. 
However, the recurrent tumor showed much more blaste-
mal components with pronounced mitoses, although there 
were no features of anaplastic changes. 
Previous reports have emphasized that long-delayed re-
currence is due to eradication of the high-grade immature 
component and the induction of a high degree of differ-
entiation, thus enhancing the disease-free interval time 
[1]. The present case could be exceptional because the re-
current tumor showed much more mitoses and pronounced 
blastemal components than did the primary tumor, which 
cannot be explained by the chemotherapy-induced matu-
ration phenomenon alone. The present case may indicate 
that chemotherapy does not always induce high-grade dif-
ferentiation with long delayed recurrence, even though the 
chemoradiation therapy might have delayed the time of re-
currence for an unknown reason. It is also possible that the Korean J Urol 2012;53:288-292
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chemoradiation therapy might have had little or no effect 
in our patient, because the therapy was given after the radi-
cal nephrectomy with no gross residual tumor. 
The pathogenesis of late relapse in Wilms’ tumor and in 
other neoplasms is not clearly understood, but several 
mechanisms have been suggested, such as escape from im-
mune vigilance, scarce vascularization in some portion of 
the tumor, and cell dependency on growth factors [8]. The 
chemoradiation therapy itself cannot explain the complex 
mechanism of late-relapsing Wilms’ tumors, and more 
studies are necessary to unveil the pathogenesis of late 
recurrence. Recent studies have indicated long-term sur-
vival after autologous stem cell rescue in Wilms’ tumor, 
ranging from 40 to 73%. However, there are very few cases 
of long-delayed recurrence with stem cell transplantation. 
Brown et al. [6] reported a late recurrent case of Wilms’ tu-
mor that was successfully treated with high-dose chemo-
therapy and autologous stem cell rescue, resulting in a 
third complete response with a disease-free interval of 15 
months post-transplant. 
After surgery, the patient received 8 fractions of 1,440 
Cgy radiation therapy on the whole abdomen and a chemo-
therapy POG 9444/CCG 4942 NWTS-5 regimen. She had 
autologous peripheral blood stem cell transplantation in 
July 2010 and has been free of recurrence or metastasis for 
14 months. 
In summary, we have reported a case of long-delayed re-
currence in a 28-year-old female patient, 25 years after the 
primary diagnosis and treatment of a Wilms’ tumor at the 
age of 3 years. This case to the best of our knowledge is the 
most delayed case of recurrence reported in the literature. 
This case illustrates that, in contrast with previously re-
ported cases, a longer delayed recurrence may show more 
malignant features compared with the primary tumor. 
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